Key result
Bariatric surgery improved insulin sensitivity within 1 week independent of caloric intake, with RYGB and LAGB leading to 5.5 kg and 5.2 kg weight loss vs 2.1 kg with very low caloric intake alone.
Why the study?
Does bariatric surgery (LAGB or RYGB) improve insulin sensitivity independently of caloric restriction in nondiabetic obese subjects?
Cohort (n=20)
Does bariatric surgery (LAGB or RYGB) improve insulin sensitivity independently of caloric restriction in nondiabetic obese subjects?
Bariatric surgery, particularly Roux-en-Y gastric bypass, improves insulin sensitivity within 1 week independently of caloric restriction in nondiabetic obese subjects.
Answers are grounded in this paper and cite their sources.
Bariatric surgery may improve early insulin sensitivity beyond caloric restriction in nondiabetic obesity; leaves open confirmation in randomized trials.
OBJECTIVE: Bariatric surgery has been shown to have important long-term metabolic effects resulting in enhanced insulin sensitivity and improved glucose tolerance in patients with type 2 diabetes. The contribution of reduced caloric intake to these beneficial effects of surgery remains unclear. The aim of this study was to compare the short-term effects (1 week) of bariatric surgical procedures with a very low caloric intake (VLCI) on insulin sensitivity (IS) and insulin secretion (ISR) in nondiabetic obese subjects. RESEARCH DESIGN AND METHODS: ) were admitted to the clinic for 1 week. At baseline and 1 week after VLCI (600 kcal/day), subjects received a hyperinsulinemic-euglycemic clamp with tracer infusion to quantify endogenous glucose production (EGP), lipolysis (rate of appearance of glycerol [RaGlycerol]), peripheral insulin sensitivity (insulin-stimulated glucose disposal [M value] divided by the steady-state plasma insulin concentration [M/I]), hepatic insulin sensitivity (Hep-IS [= 1/(EGP ⋅ insulin)]), and adipose insulin sensitivity (Adipo-IS [= 1/(RaGlycerol ⋅ insulin)]). An intravenous glucose bolus was administered at the end of the insulin clamp to measure ISR and β-cell function (disposition index [DI]). Approximately 3 months later, patients were admitted for laparoscopic adjustable gastric banding (LAGB) (n = 10) or Roux-en-Y gastric bypass (RYGB) (n = 10), and were restudied 1 week after surgery under the same caloric regimen (600 kcal/day). RESULTS: After 1 week of VLCI, patients lost 2.1 kg without significant changes in Hep-IS, Adipo-IS, M/I, or DI. RYGB and LAGB led to greater weight loss (5.5 and 5.2 kg, respectively) and to significant improvement in Hep-IS, EGP, and lipolysis. Only RYGB improved Adipo-IS and M/I. No change in ISR or DI was observed in either surgical group. CONCLUSIONS: Bariatric surgery improves IS within 1 week. These metabolic effects were independent of caloric intake and more pronounced after RYGB compared with LAGB.
No takes yet. Share an insight, caveat, or question.
Gastaldelli et al. (2016) conducted a cohort in Nondiabetic obesity (n=20). Laparoscopic adjustable gastric banding (LAGB) or Roux-en-Y gastric bypass (RYGB) vs. Very low caloric intake (VLCI) was evaluated on Insulin sensitivity (IS) and insulin secretion (ISR). Bariatric surgery improved insulin sensitivity within 1 week independent of caloric intake, with RYGB and LAGB leading to 5.5 kg and 5.2 kg weight loss vs 2.1 kg with very low caloric intake alone.
Synapse has enriched 10 related papers. Consider them for comparative context: